02 March 1998
Peri-operative hemodilution in intracranial aneurysm surgery
Danuta Mitosek-Sabbo, Tomasz Trojanowski, Marian CzochraMed Sci Monit 1998; 4(2): CR292-296 :: ID: 502607
Abstract
Delayed cerebral ischemia is the major cause of death and disability in patients suffering from an aneurysmal subarachnoid hemorrhage (SAH). A method of reducing the risk of ischemic deficits during surgery is based on the improvement of brain microcirculation by means of hemodilution. This study presents 80 patients who underwent surgery due to SAH for ruptured intracranial aneurysms. Fifty were selected and underwent perioperative hemodilution. The other 30 comprised the control group. There were no statistically significant differences in the composition of these groups in regard to the commonly recognized prognostic factors. Moore's method was used to evaluate the circulating blood volume in patients operated on with normovolemic hemodilution. After the induction of anesthesia, 20% of the estimated volume of circulating blood was extracted and replaced by Dextran 70 000 and Ringer solution in equal parts. At the time of aneurysm clipping the hematocrit level was lowered to 0.30. In the control group it equaled 0.37. Blood was retransfused directly after aneurysm clipping or during the peri-operative bleeding. The results of treatment were evaluated at the end of the hospital stay as well as one and six months following discharge using the Glasgow Outcome Scale (GOS). Early results evaluated at the time of discharge were better in the group who were operated on using hemodilution than in the control group (GOS I-II 78% and 63.4% respectively). Surgical treatment of intracranial aneurysms using hemodilution, evaluated 6 months following discharge showed good results (GOS Grade I) in about 10% more of hemodiluted patients then in the control group. The difference was statistically significant. In addition, perioperative hemodilution reduced the need for blood transfusions.
Keywords: peri-operative hemodilution, intracranial aneurysm surgery
Editorial
01 January 2026 : Editorial
Editorial: Increasing Awareness of Lung Cancer in Non-Smokers and Never-Smokers Challenges Current Approaches to Prevention and ScreeningDOI: 10.12659/MSM.952454
Med Sci Monit 2026; 32:e952454
In Press
Clinical Research
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...Med Sci Monit In Press; DOI: 10.12659/MSM.951027
Clinical Research
Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...Med Sci Monit In Press; DOI: 10.12659/MSM.950516
Review article
Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.951283
Clinical Research
Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 AdultsMed Sci Monit In Press; DOI: 10.12659/MSM.950938
Most Viewed Current Articles
17 Jan 2024 : Review article 10,187,196
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,708,487
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,341,643
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 706,524
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387






